Skip to main content
Erschienen in: Acta Neurologica Belgica 1/2018

05.12.2017 | Original Article

Sleep quality is associated with the severity of clinical symptoms in Parkinson’s disease

verfasst von: Bruno T. Junho, Arthur Kummer, Francisco E. Cardoso, Antonio L. Teixeira, Natalia P. Rocha

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Sleep disorders are very common in Parkinson’s disease (PD), being associated with several other conditions, mainly psychiatric disorders. The present study was designed to assess sleep quality in Brazilian patients with PD and to evaluate whether sleep changes are associated with clinical variables, especially neuropsychiatric symptoms in PD. Patients diagnosed with PD were subjected to a comprehensive clinical evaluation that included the assessment of motor, cognitive and psychiatric symptoms. Our study showed that sleep complaints are frequent in PD and worse sleep quality is associated with depressive and anxious symptoms, poorer cognitive performance and greater severity of PD symptoms. In the multivariate analysis, older age, greater severity of anxiety and PD remained as significant predictors of worse sleep quality. In conclusion, sleep complaints, depressive and anxiety symptoms are frequent in PD patients. Older age, disease severity and anxiety symptoms are significant predictors of poorer sleep quality in PD patients.
Literatur
3.
Zurück zum Zitat Kummer A, Teixeira AL (2009) Neuropsychiatry of Parkinson’s disease. Arq Neuropsiquiatr 67(3B):930–939CrossRefPubMed Kummer A, Teixeira AL (2009) Neuropsychiatry of Parkinson’s disease. Arq Neuropsiquiatr 67(3B):930–939CrossRefPubMed
8.
Zurück zum Zitat Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649. https://doi.org/10.1002/mds.22643 CrossRefPubMed Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649. https://​doi.​org/​10.​1002/​mds.​22643 CrossRefPubMed
14.
Zurück zum Zitat Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Hogl B, Trenkwalder C (2002) The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 73(6):629–635CrossRefPubMedPubMedCentral Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Hogl B, Trenkwalder C (2002) The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 73(6):629–635CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Jongwanasiri S, Prayoonwiwat N, Pisarnpong A, Srivanitchapoom P, Chotinaiwattarakul W (2014) Evaluation of sleep disorders in Parkinson’s disease: a comparison between physician diagnosis and self-administered questionnaires. J Med Assoc Thai 97(Suppl 3):S68–77PubMed Jongwanasiri S, Prayoonwiwat N, Pisarnpong A, Srivanitchapoom P, Chotinaiwattarakul W (2014) Evaluation of sleep disorders in Parkinson’s disease: a comparison between physician diagnosis and self-administered questionnaires. J Med Assoc Thai 97(Suppl 3):S68–77PubMed
16.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRefPubMedPubMedCentral Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Fahn S (1987) Recent developments in Parkinson’s disease. Macmillan Health care Inf 2:293–304 Fahn S (1987) Recent developments in Parkinson’s disease. Macmillan Health care Inf 2:293–304
18.
Zurück zum Zitat Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L (2004) Movement disorder society task force report on the hoehn and yahr staging scale: status and recommendations. Mov Disord 19(9):1020–1028. https://doi.org/10.1002/mds.20213 CrossRefPubMed Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L (2004) Movement disorder society task force report on the hoehn and yahr staging scale: status and recommendations. Mov Disord 19(9):1020–1028. https://​doi.​org/​10.​1002/​mds.​20213 CrossRefPubMed
19.
Zurück zum Zitat Folstein MF, Robins LN, Helzer JE (1983) The mini-mental state examination. Arch Gen Psychiatry 40(7):812CrossRefPubMed Folstein MF, Robins LN, Helzer JE (1983) The mini-mental state examination. Arch Gen Psychiatry 40(7):812CrossRefPubMed
20.
Zurück zum Zitat Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55(11):1621–1626CrossRefPubMed Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55(11):1621–1626CrossRefPubMed
21.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed
23.
24.
Zurück zum Zitat McRae C, Diem G, Vo A, O’Brien C, Seeberger L (2002) Reliability of measurements of patient health status: a comparison of physician, patient, and caregiver ratings. Parkinsonism Relat Disord 8(3):187–192CrossRefPubMed McRae C, Diem G, Vo A, O’Brien C, Seeberger L (2002) Reliability of measurements of patient health status: a comparison of physician, patient, and caregiver ratings. Parkinsonism Relat Disord 8(3):187–192CrossRefPubMed
25.
Zurück zum Zitat Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545CrossRefPubMed Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545CrossRefPubMed
28.
Zurück zum Zitat Kummer A, Cardoso F, Teixeira AL (2010) Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson’s disease. Arq Neuropsiquiatr 68:495–501CrossRefPubMed Kummer A, Cardoso F, Teixeira AL (2010) Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson’s disease. Arq Neuropsiquiatr 68:495–501CrossRefPubMed
32.
Zurück zum Zitat Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG (1995) Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18(6):425–432CrossRefPubMed Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG (1995) Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18(6):425–432CrossRefPubMed
36.
Zurück zum Zitat Yamanishi T, Tachibana H, Oguru M, Matsui K, Toda K, Okuda B, Oka N (2013) Anxiety and depression in patients with Parkinson’s disease. Internal Med (Tokyo) 52(5):539–545CrossRef Yamanishi T, Tachibana H, Oguru M, Matsui K, Toda K, Okuda B, Oka N (2013) Anxiety and depression in patients with Parkinson’s disease. Internal Med (Tokyo) 52(5):539–545CrossRef
38.
Zurück zum Zitat Kummer A, Cardoso F, Teixeira AL (2010) Generalized anxiety disorder and the hamilton anxiety rating scale in Parkinson’s disease. Arq Neuropsiquiatr 68(4):495–501CrossRefPubMed Kummer A, Cardoso F, Teixeira AL (2010) Generalized anxiety disorder and the hamilton anxiety rating scale in Parkinson’s disease. Arq Neuropsiquiatr 68(4):495–501CrossRefPubMed
41.
Zurück zum Zitat Margis R, Donis KC, Schonwald SV, Rieder CR (2010) WHOQOL-OLD assessment of quality of life in elderly patients with Parkinson’s disease: influence of sleep and depressive symptoms. Revista Brasileira de Psiquiatria (Sao Paulo) 32(2):125–131CrossRef Margis R, Donis KC, Schonwald SV, Rieder CR (2010) WHOQOL-OLD assessment of quality of life in elderly patients with Parkinson’s disease: influence of sleep and depressive symptoms. Revista Brasileira de Psiquiatria (Sao Paulo) 32(2):125–131CrossRef
42.
Zurück zum Zitat Young A, Home M, Churchward T, Freezer N, Holmes P, Ho M (2002) Comparison of sleep disturbance in mild versus severe Parkinson’s disease. Sleep 25(5):573–577CrossRefPubMed Young A, Home M, Churchward T, Freezer N, Holmes P, Ho M (2002) Comparison of sleep disturbance in mild versus severe Parkinson’s disease. Sleep 25(5):573–577CrossRefPubMed
43.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442CrossRefPubMed Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442CrossRefPubMed
44.
Zurück zum Zitat Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P (2001) Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology 56(6):730–736CrossRefPubMed Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P (2001) Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology 56(6):730–736CrossRefPubMed
48.
Zurück zum Zitat Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y (2002) Parkinson’s disease and sleepiness: an integral part of PD. Neurology 58(7):1019–1024CrossRefPubMed Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y (2002) Parkinson’s disease and sleepiness: an integral part of PD. Neurology 58(7):1019–1024CrossRefPubMed
Metadaten
Titel
Sleep quality is associated with the severity of clinical symptoms in Parkinson’s disease
verfasst von
Bruno T. Junho
Arthur Kummer
Francisco E. Cardoso
Antonio L. Teixeira
Natalia P. Rocha
Publikationsdatum
05.12.2017
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 1/2018
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-017-0868-6

Weitere Artikel der Ausgabe 1/2018

Acta Neurologica Belgica 1/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.